Dr. med. Jochen Maul, FEBGH
Dr. med. Jochen Maul, FEBGH
Gastroenterologist, Gastroenterologie am Bayerischen Platz, Berlin; visiting scholar Charité
Verified email at - Homepage
Cited by
Cited by
Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease
J Maul, C Loddenkemper, P Mundt, E Berg, T Giese, A Stallmach, M Zeitz, ...
Gastroenterology 128 (7), 1868-1878, 2005
Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans
P Bacher, T Hohnstein, E Beerbaum, M Röcker, MG Blango, S Kaufmann, ...
Cell 176 (6), 1340-1355. e15, 2019
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
K Rieger, C Loddenkemper, J Maul, T Fietz, D Wolff, H Terpe, B Steiner, ...
Blood 107 (4), 1717-1723, 2006
Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART
HJ Epple, C Loddenkemper, D Kunkel, H Tröger, J Maul, V Moos, ...
Blood 108 (9), 3072-3078, 2006
Use of intestinal ultrasound to monitor Crohn’s disease activity
T Kucharzik, BM Wittig, U Helwig, N Börner, A Rössler, S Rath, C Maaser, ...
Clinical Gastroenterology and Hepatology 15 (4), 535-542. e2, 2017
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice–a nationwide consecutive German cohort study
DC Baumgart, B Bokemeyer, A Drabik, A Stallmach, S Schreiber, ...
Alimentary pharmacology & therapeutics 43 (10), 1090-1102, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease–a prospective multicenter observational study
A Stallmach, C Langbein, R Atreya, T Bruns, A Dignass, K Ende, J Hampe, ...
Alimentary pharmacology & therapeutics 44 (11-12), 1199-1212, 2016
The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy
CRH Hedin, SR Vavricka, AJ Stagg, A Schoepfer, T Raine, L Puig, ...
Journal of Crohn's and Colitis 13 (5), 541-554, 2019
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection
S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ...
Clinical Gastroenterology and Hepatology 7 (9), 981-987, 2009
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ...
Journal of Crohn's and Colitis 4 (2), 194-198, 2010
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy
JF Rahier, P Papay, J Salleron, S Sebastian, M Marzo, L Peyrin-Biroulet, ...
Gut 60 (4), 456-462, 2011
Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome
M Heindl, N Händel, J Ngeow, J Kionke, C Wittekind, M Kamprad, ...
Gastroenterology 142 (5), 1093-1096. e6, 2012
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled study
F Beigel, N Teich, S Howaldt, F Lammert, J Maul, S Breiteneicher, C Rust, ...
Journal of Crohn's and Colitis 8 (11), 1471-1479, 2014
EndoClot polysaccharide hemostatic system in nonvariceal gastrointestinal bleeding: results of a prospective multicenter observational pilot study
JC Preiß, C Barmeyer, N Bürgel, S Daum, HJ Epple, U Günther, J Maul, ...
Journal of clinical gastroenterology 50 (10), e95-e100, 2016
Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations
J Maul, M Zeitz
Langenbeck's archives of surgery 397, 1-10, 2012
Modulation of systemic antigen‐specific immune responses by oral antigen in humans
K Kapp, J Maul, A Hostmann, P Mundt, JC Preiss, A Wenzel, A Thiel, ...
European journal of immunology 40 (11), 3128-3137, 2010
Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis
G Fluhr, J Mayerle, E Weber, A Aghdassi, P Simon, T Gress, T Seufferlein, ...
BMC gastroenterology 13, 1-6, 2013
Analysis of FOXP3 protein expression in human CD4 (+) CD25 (+) regulatory T cells at the single-cell level
C Loddenkemper, J Maul, E Berg, H Stein, M Zeitz, R Duchmann
European journal of immunology 36 (1), 245-246, 2006
Level of tumor necrosis factor production by stimulated blood mononuclear cells can be used to predict response of patients with inflammatory bowel diseases to infliximab
B Jessen, Y Rodriguez-Sillke, E Sonnenberg, M Schumann, A Kruglov, ...
Clinical Gastroenterology and Hepatology 19 (4), 721-731. e1, 2021
Simultaneous Presence of Non-and Highly Mutated Keyhole Limpet Hemocyanin (KLH)-Specific Plasmablasts Early after Primary KLH Immunization Suggests Cross-Reactive Memory B Cell …
C Giesecke, T Meyer, P Durek, J Maul, J Preiß, JFM Jacobs, A Thiel, ...
The Journal of Immunology 200 (12), 3981-3992, 2018
The system can't perform the operation now. Try again later.
Articles 1–20